Literature DB >> 15291786

The induction of laboratory-based amoebic gill disease revisited.

R N Morrison1, P B B Crosbie, B F Nowak.   

Abstract

Previous work in our laboratory defined a method of inducing laboratory-based amoebic gill disease (AGD) in Atlantic salmon, Salmo salar L. Gills of AGD-affected fish were scraped and the debris placed into fish-holding systems, eliciting AGD in naïve Atlantic salmon. While this method is consistently successful in inducing AGD, variability in the kinetics and severity of infections has been observed. It is believed that the infections are influenced by inherently variable viability of post-harvest amoeba trophozoites. Here, a new method of experimental induction of AGD is presented that redefines the infection model including the minimum infective dose. Amoebae were partially purified from the gills of AGD-affected Atlantic salmon. Trophozoites were characterized by light microscopy and immunocytochemistry and designated Neoparamoeba sp., possibly Neoparamoeba pemaquidensis. Cells were placed into experimental infection systems ranging in concentration from 0 to 500 cells L(-1). AGD was detected by gross and histological examination in fish held in all systems inoculated with amoebae. The number of gross and histological AGD lesions per gill was proportional to the inoculating concentration of amoebae indicating that the severity of disease is a function of amoeba density in the water column. The implications of these observations are discussed in the context of the existing AGD literature base as well as Atlantic salmon farming in south-eastern Tasmania.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291786     DOI: 10.1111/j.1365-2761.2004.00561.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  9 in total

1.  The viscosity and glycoprotein biochemistry of salmonid mucus varies with species, salinity and the presence of amoebic gill disease.

Authors:  Shane D Roberts; Mark D Powell
Journal:  J Comp Physiol B       Date:  2004-10-29       Impact factor: 2.200

2.  Evaluation of Low Temperature and Salinity as a Treatment of Atlantic Salmon against Amoebic Gill Disease.

Authors:  Jemma Hudson; Mark Adams; Khattapan Jantawongsri; Tim Dempster; Barbara F Nowak
Journal:  Microorganisms       Date:  2022-01-18

3.  Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression.

Authors:  James W Wynne; Maree G O'Sullivan; Mathew T Cook; Glenn Stone; Barbara F Nowak; David R Lovell; Nicholas G Elliott
Journal:  Mar Biotechnol (NY)       Date:  2008-01-25       Impact factor: 3.619

4.  Effect of repeated exposure to AQUI-S® on the viability and growth of Neoparamoeba perurans.

Authors:  R J Chance; Z Allcock; C J Secombes; B Collet; C Collins
Journal:  J Fish Dis       Date:  2017-09-25       Impact factor: 2.767

5.  Non-lethal loop-mediated isothermal amplification assay as a point-of-care diagnostics tool for Neoparamoeba perurans, the causative agent of amoebic gill disease.

Authors:  Irene Cano; Robin McCullough; Brian Mulhearn; Susie Gunning; Ava Waine; Claire Joiner; Richard Paley
Journal:  J Fish Dis       Date:  2020-05-04       Impact factor: 2.767

6.  Effects of cnidarian biofouling on salmon gill health and development of amoebic gill disease.

Authors:  Nina Bloecher; Mark Powell; Sigurd Hytterød; Mona Gjessing; Jannicke Wiik-Nielsen; Saima N Mohammad; Joachim Johansen; Haakon Hansen; Oliver Floerl; Anne-Gerd Gjevre
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

7.  The Effect of Antimicrobial Treatment upon the Gill Bacteriome of Atlantic Salmon (Salmo salar L.) and Progression of Amoebic Gill Disease (AGD) In Vivo.

Authors:  Joel Slinger; Mark B Adams; Chris N Stratford; Megan Rigby; James W Wynne
Journal:  Microorganisms       Date:  2021-05-02

8.  In vitro gill cell monolayer successfully reproduces in vivo Atlantic salmon host responses to Neoparamoeba perurans infection.

Authors:  Irene Cano; Nick Gh Taylor; Amanda Bayley; Susie Gunning; Robin McCullough; Kelly Bateman; Barbara F Nowak; Richard K Paley
Journal:  Fish Shellfish Immunol       Date:  2018-11-17       Impact factor: 4.581

Review 9.  Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease.

Authors:  Jemma Hudson; Barbara F Nowak
Journal:  Microorganisms       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.